new-recommended-broker-banner new-recommended-broker-banner

Braveheart Shares Surge 15.2% on New COVID-19 Mask

Updated: 23 Oct 2020

Shares of Braveheart Investment Group plc (LON: BRH) today surged 15.2% after the company announced that it could start selling a new antiviral face mask that can kill the coronavirus COVID-19 by the end of the year.

Investors cheered the news given the recent flurry of activities at Pharm2Farm (P2F), a Braveheart investee company, which created a textile coating with nanoparticles that have long-lasting virucidal properties.

Braveheart revealed that it has final test results from two independent labs showing that the masks have a ‘kill rate’ of over 90% that can last up to seven hours, hence, qualifying for ISO 18184 certification.

new-recommended-broker-banner

ISO 18184 certification is the international benchmark for antiviral activity in fabrics set by the International Organization for Standardization (ISO). Pharm2Farm has applied for a patent to protect the intellectual property behind the unique coating technology.

Braveheart also revealed that it is building an automated mask production line that can produce 5 million masks a month, which should be ready by end of December. The company also sold its 51.72% stake in P2F to Remote Monitored Systems Plc (RMS) and will now own 37.12% of RMS.

Braveheart share price

Tradingview chart of Braveheart share price 23102020

Braveheart shares today surged 15.2% to trade at 38p having gapped higher from Thursday’s closing price of 33p.

People who read this also read:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .